<DOC>
	<DOC>NCT01423474</DOC>
	<brief_summary>The purpose of this study is to compare the toxicity of two new radiation schedules for the treatment of prostate cancer. Patients will be randomized to receive 5 treatments delivered every other day over 11 days, or once per week over 29 days. Both of these schedules are shorter than the standard treatment which is usually 39 treatments over 8 weeks.</brief_summary>
	<brief_title>Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Low or intermediate risk prostate cancer patients as defined by: Clinical stage T12b, Gleason Score &lt;=7, and PSA &lt;=20 ng/mL Age &gt;= 18 years Androgen deprivation therapy (LHRHagonists or antiandrogens) &gt;6 months Prior pelvic radiotherapy Anticoagulation medication (if unsafe to discontinue for gold seed insertion) Diagnosis of bleeding diathesis Large prostate (&gt;90cm3) on imaging Immunosuppressive medications Inflammatory bowel disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Hypofractionation</keyword>
</DOC>